Dapoxetine Hydrochloridis CAS 129938-20-1 Intret ≥99.0% API Factory High Quality Featured Image

Dapoxetine hydrochloride CAS 129938-20-1 Intende ≥99.0% API Factory High Quality

Description:

Nomen chemicum: Dapoxetine hydrochloridum

CAS: 129938-20-1

Aspectus: Albus in Crystallino Powder fere Albus

Dic: ≥99.0%

SSRI Inhibitor tractare Praematura Ejaculation (PE) in Men

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Dapoxetine Hydrochloride Commercial Supple et intermedia Related:
3-Chloropropiophenone CAS: 936-59-4
(S) -3-Amino-3-Phenylpropan-1-ol CAS: 82769-76-4
(S) -3-Amino-3-Phenylpropanoicum Acidum CAS: 40856-44-8
(R) -Diphenylprolinol CAS: 22348-32-9
(S) -Diphenylprolinol CAS: 112068-01-6
(S)-(-)-3-Chloro-1-Phenyl-1-Propanol CAS: 100306-34-1
Dapoxetine Hydrochloridis CAS: 129938-20-1

Chemical Properties:

Nomen chemicum	Dapoxetine hydrochloride
Synonyma	Dapoxetine HCl;LY-210448 Hydrochloride;Priligy;(S)-N,N-Dimethyl-3-(1-naphthyloxy)-1-phenylpropylamine Hydrochloride
CAS Number	129938-20-1
CATTUS Number	RF-API92
Stock Status	In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae	C21H23NO·HCl
M. Pondus	341.88
Repono Temperature	Locus temperatus
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad fere alba Crystallina pulveris
Lepidium sativum	IR
Assay	≥99.0%
Liquescens punctum	175.0~182.0℃
Damnum in Siccatio	≤1.0%
Residere in Ignition	≤0.10%
Imprimis Rotationes	+126.0°~130.0°(C=1, CH3OH)
Metalla gravis	≤10ppm
Chromatographic immunditias
una immunditia	≤0.20%
Totalis immunditias	≤1.0%
RELICTUM Solvents	Meets opus est
Test Standard	Enterprise Standard
Consuetudinem	API, SSRI Inhibitor tractationis Praematurae Ejaculationis (PE) in Men

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

Hydrochloridum Dapoxetinum (CAS 129938-20-1) primum est pharmaceuticum, novum breve activum selectivum serotonin reuptake inhibitor (SSRI) venales ad curationem praematura ejaculationis in men18-64 annorum.Praematura ejaculatio (PE) est frequentissima turbatio sexualis masculina, aestimatur afficere usque ad 30% hominum.Curatio Dapoxetina plerumque bene tolerata est, cum humilis incidentias discontinuationis syndromae, dysfunctiones sexualis, et symptomata modus curationi-emergentium.Opera Dapoxetina inhibendo transportatorem serotonin, actionem serotonin in post fissuram synapticam augendam, et consequenter mora ejaculatoria promovenda.Cum membrum familiae selectivae serotonin reuptake inhibitor (SSRI) familia, dapoxetina initio antidepressant creatus est.Sed, dissimiles aliis SSRIS, dapoxetine absorbetur et eliminatur celeriter in corpore.Proprietas eius ieiunium agendi facit idoneum ad curationem PE sed non ut antidepressant.